Cargando…
Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671407/ https://www.ncbi.nlm.nih.gov/pubmed/29124013 http://dx.doi.org/10.1016/j.ymgmr.2017.10.005 |
| _version_ | 1783276232527314944 |
|---|---|
| author | Finsterer, Josef Zarrouk-Mahjoub, Sinda |
| author_facet | Finsterer, Josef Zarrouk-Mahjoub, Sinda |
| author_sort | Finsterer, Josef |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5671407 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56714072017-11-09 Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism Finsterer, Josef Zarrouk-Mahjoub, Sinda Mol Genet Metab Rep Letter to the Editor Elsevier 2017-10-26 /pmc/articles/PMC5671407/ /pubmed/29124013 http://dx.doi.org/10.1016/j.ymgmr.2017.10.005 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Finsterer, Josef Zarrouk-Mahjoub, Sinda Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism |
| title | Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism |
| title_full | Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism |
| title_fullStr | Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism |
| title_full_unstemmed | Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism |
| title_short | Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism |
| title_sort | fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671407/ https://www.ncbi.nlm.nih.gov/pubmed/29124013 http://dx.doi.org/10.1016/j.ymgmr.2017.10.005 |
| work_keys_str_mv | AT finstererjosef fibroblastgrowthfactor21iscurrentlyaweakbiomarkerforidentifyingmitochondrialandnonmitochondrialinbornerrorsofmetabolism AT zarroukmahjoubsinda fibroblastgrowthfactor21iscurrentlyaweakbiomarkerforidentifyingmitochondrialandnonmitochondrialinbornerrorsofmetabolism |